Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 20CNS 11Sarcoma 8Head & Neck 8Thoracic 6Breast 6Genitourinary 4Dermatologic 3Tumor-Agnostic 1Gynecologic 1Classical hematology 1

Conditions

Pelvic Neoplasms 1Head and Neck Neoplasms 1

Interventions

Paclitaxel 74pembrolizumab 59Carboplatin 55Bevacizumab 55Specimen Handling 47Magnetic Resonance Spectroscopy 39Cisplatin 34olaparib 28Gemcitabine 26liposomal doxorubicin 24Biopsy 20Taxes 18Topotecan 17Nivolumab 17Doxorubicin 15Cyclophosphamide 15Immunoglobulin G 14Disulfides 14niraparib 12fludarabine 12Letrozole 12lenvatinib 11Surveys and Questionnaires 11atezolizumab 10Drug Therapy 10Brachytherapy 10durvalumab 9Radiotherapy 9Fulvestrant 9Docetaxel 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Surgical Procedures, Operative × Gynecologic × 90 days × Clear all
NCT06915727 2026-04-01

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Mayo Clinic

Phase 3 Recruiting
20 enrolled
GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡